The guessing game about when, how and if the UK will exit the European Union (EU) goes on, with the views of pharma professionals still showing a range of predicted outcomes.
GlobalData’s Brexit tracker has been updated to reflect the latest views of these professionals, who will likely have an eye on the UK election this week to see what the next stage in the long saga is likely to be.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze